About Ardelyx (ARDX)
Ardelyx, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutics focuses on addressing cardiorenal and gastrointestinal (GI) diseases. It operates through the research, development and commercialization of biopharmaceutical pro... Read more
- USD4.22
- USD4.32
- USD4.17
- USD7.18
- 8.70%
- 362M
- 2.84M
- 4.45M
- 883M
- 3.21
- -19.70%
Stock News
2 hours ago
Dow Jones Futures: Trump Tariffs Back In Focus; Tesla Rival Uber Leads 5 Stocks In Buy Zones
Yahoo
9 hours ago
Happiness researcher shares his '90-second rule' to live a better, more fulfilled life—it helps when you're angry or upset
CNBC
10 hours ago
Retirees are flocking to these 10 U.S. states—No. 1 offers low taxes and sunny weather
CNBC
11 hours ago
Fast-casual restaurants lean on loyalty programs to offset consumer pullback
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
